Your browser doesn't support javascript.
loading
Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin.
Suzuki, Takuya; Ichihara, Masako; Hyodo, Kenji; Yamamoto, Eiichi; Ishida, Tatsuhiro; Kiwada, Hiroshi; Kikuchi, Hiroshi; Ishihara, Hiroshi.
Affiliation
  • Suzuki T; DDS Research, Global Formulation Research Japan, Pharmaceutical Science and Technology, Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan. Electronic address: t25-suzuki@hhc.eisai.co.jp.
  • Ichihara M; Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima; 1-78-1, Sho-machi, Tokushima 770-8505, Japan.
  • Hyodo K; DDS Research, Global Formulation Research Japan, Pharmaceutical Science and Technology, Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
  • Yamamoto E; DDS Research, Global Formulation Research Japan, Pharmaceutical Science and Technology, Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
  • Ishida T; Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima; 1-78-1, Sho-machi, Tokushima 770-8505, Japan.
  • Kiwada H; Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima; 1-78-1, Sho-machi, Tokushima 770-8505, Japan.
  • Kikuchi H; Formulation Strategy, Global Formulation Research, Pharmaceutical Science and Technology, Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
  • Ishihara H; DDS Research, Global Formulation Research Japan, Pharmaceutical Science and Technology, Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
Int J Pharm ; 476(1-2): 205-12, 2014 Dec 10.
Article in En | MEDLINE | ID: mdl-25280884
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin M / Doxorubicin / Antibiotics, Antineoplastic Limits: Animals Language: En Journal: Int J Pharm Year: 2014 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin M / Doxorubicin / Antibiotics, Antineoplastic Limits: Animals Language: En Journal: Int J Pharm Year: 2014 Document type: Article Country of publication: